enVVeno Medical Corporation (NVNO)

enVVeno Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	77	68	48	62	17	10
Market Cap Growth	63.42%	41.70%	-22.58%	262.30%	74.72%	-42.97%
Enterprise Value	34	23	11	10	9	9
PE Ratio	-	-2.91	-1.96	-3.77	-1.77	-1.29
PS Ratio	-	-	-	-	-	315.50
PB Ratio	1.78	1.48	1.25	1.15	2.43	9.96
P/FCF Ratio	-4.18	-3.62	-3.07	-5.11	-2.19	-1.57
P/OCF Ratio	-4.19	-3.63	-3.09	-5.27	-2.24	-1.67
EV/Sales Ratio	-	-	-	-	-	275.15
EV/EBITDA Ratio	-1.43	-1.02	-0.45	-0.60	-1.00	-1.18
EV/EBIT Ratio	-1.39	-1.00	-0.45	-0.59	-0.96	-1.12
EV/FCF Ratio	-1.78	-1.24	-0.70	-0.79	-1.12	-1.37
Debt / Equity Ratio	0.03	0.03	0.04	0.04	0.12	0.87
Debt / EBITDA Ratio	-0.06	-0.06	-0.07	-0.12	-0.10	-0.12
Debt / FCF Ratio	-0.08	-0.07	-0.11	-0.16	-0.11	-0.14
Quick Ratio	28.88	33.85	25.52	34.64	2.93	1.13
Current Ratio	29.08	34.23	25.78	34.84	3.00	0.76
Asset Turnover	0	0	0	0	0	0.01
Return on Equity (ROE)	-62.20%	-70.20%	-55.00%	-33.70%	-318.20%	-263.10%
Return on Assets (ROA)	-57.60%	-64.70%	-51.60%	-32.40%	-161.80%	-139.10%
Return on Capital (ROIC)	-54.81%	-53.02%	-61.64%	-29.95%	-114.50%	-415.65%
Earnings Yield	-29.31%	-34.36%	-51.07%	-26.49%	-56.57%	-77.36%
FCF Yield	-22.98%	-27.60%	-32.57%	-19.58%	-45.62%	-63.51%
Buyback Yield / Dilution	-42.97%	-9.54%	-29.38%	-572.10%	-104.86%	-68.34%
Total Shareholder Return	-42.97%	-9.54%	-29.38%	-572.10%	-104.86%	-68.34%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).